0000950170-24-026234.txt : 20240305
0000950170-24-026234.hdr.sgml : 20240305
20240305170751
ACCESSION NUMBER: 0000950170-24-026234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huller Kelly
CENTRAL INDEX KEY: 0001768417
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 24722116
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDOBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
ownership.xml
4
X0508
4
2024-03-01
0001237831
GLOBUS MEDICAL INC
GMED
0001768417
Huller Kelly
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
false
true
false
false
SVP, GC, Corporate Secretary
true
Class A Common Stock
2024-03-01
4
M
false
7500
24.90
A
7500
D
Class A Common Stock
2024-03-01
4
S
false
4385
53.79
D
3115
D
Class A Common Stock
2024-03-01
4
S
false
3115
54.53
D
0
D
Stock Option (Right to Buy Class A Common Stock)
24.90
2024-03-01
4
M
false
7500
0
D
2024-03-04
Class A Common Stock
7500
0
D
This sale was effected pursuant to a Rule 10b5-1 trading plan dated September 7, 2023 executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $53.36 - $54.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $54.43 - $54.64, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (3) to this Form 4.
These options were granted on March 4, 2014 and are fully vested.
/s/ Kelly G. Huller
2024-03-05